1. Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment;Kate Gadanec;Fut. Med.,2021
2. In silico analyses on the comparative potential of therapeutic human monoclonal antibodies against newly emerged SARS-CoV-2 variants bearing mutant spike protein;Das;Front. Immunol.,2021
3. Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach;Choudhury;Future Virol.,2021
4. SARS-CoV-2: an overview of virus genetics, transmission, and immunopathogenesis;Farrag;Int. J. Environ. Res. Publ. Health,2021
5. Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells;Law;BMC Immunol.,2009